危重症相关心脏骤停(CIRCA):英国重症监护病房内心脏骤停发生率与结局的前瞻性研究
该研究为12个月前瞻性观察性研究,纳入英国93个成人ICU,共53,620例患者,其中726例在ICU内发生院内心脏骤停(IHCA),发生比例为1.4%(95%CI 1.3-1.5%)。35.4%存活至ICU出院,29.6%存活至医院出院,18.7%存活至12个月。逻辑回归显示男性、非白人或不详种族、入ICU前24小时内CPR、入ICU来源/原因与IHCA风险增加相关;ROSC后年龄增加、COVID-19和复苏持续时间延长与出院存活概率降低相关。存活者生活质量降低。作者指出疫情相关研究中断降低了结果确定性,并强调种族、亚表型及危重症心脏骤停特异性试验为需进一步研究领域。
要点
- 英国93个成人ICU的53,620例患者中,726例发生ICU内IHCA,发生比例为1.4%(95%CI 1.3-1.5%)。
- ICU内IHCA后35.4%存活至ICU出院,29.6%存活至医院出院,18.7%存活至12个月。
- 男性、非白人或不详种族、入ICU前24小时内CPR、入ICU来源/原因与ICU内IHCA风险增加相关。
- ROSC后年龄增加、COVID-19和复苏持续时间延长与出院存活概率降低相关。
- 存活者生活质量降低;作者指出疫情相关研究中断降低了结果确定性。
适用人群与场景
- 英国93个成人ICU的53,620例患者,研究期间为12个月,招募期因COVID-19疫情前两波而调整。
研究设计与关键结果
- 研究类型:12个月前瞻性观察性研究,数据与两个国家临床审计链接;纳入英国93个成人ICU。
- 主要终点:53,620例患者中726例发生ICU内IHCA,发生比例1.4%(95%CI 1.3-1.5%)。
- 结局:35.4%存活至ICU出院,29.6%存活至医院出院,18.7%存活至12个月。
- 逻辑回归:男性、非白人或不详种族、入ICU前24小时内CPR、入ICU来源/原因与ICU内IHCA风险增加相关。
- ROSC后:年龄增加、COVID-19和复苏持续时间延长与出院存活概率降低相关。
- 存活者生活质量降低。
证据类型、等级与局限
- 证据类型:前瞻性观察性研究,注册于ClinicalTrials.gov(NCT04219384,2020年1月7日注册)。
- 局限:疫情相关研究中断降低了结果确定性;作者指出种族、亚表型及危重症心脏骤停特异性试验为需进一步研究领域。
对床旁实践的改变
- 作者认为,种族、亚表型及危重症心脏骤停特异性试验是需进一步研究的领域,以降低发生率和改善结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cardiac arrest is frequently categorised by the event location, capturing differences in epidemiology, response and outcome. In the United Kingdom (UK) the National Cardiac Arrest Audit excludes arrests not attended by the resuscitation team, such as in many Intensive Care Units (ICU). Differences in staffing and skill mix within ICUs mean the risk of cardiac arrest occurring, the involvement (or not) of the resuscitation team, and the probability of return of spontaneous circulation (ROSC) are all likely to differ from other locations. This study aimed to determine the incidence proportion, risk factors and outcomes of in-hospital cardiac arrest (IHCA) in the ICU.
METHODS: This was a 12-month prospective observational study of in-hospital cardiac arrest within 93 adult ICUs in the UK with data linkage to two national clinical audits. The recruitment period was adapted to accommodate the first two waves of the COVID-19 pandemic.
RESULTS: In a 53,620 patient cohort, 726 experienced IHCA in ICU [Incidence proportion = 1.4 % (95 % CI 1.3-1.5 %)]. Of these, 35.4 % and 29.6 % survived to ICU and hospital discharge and 18.7 % survived to 12 months. Logistic regression revealed male sex, non-white or not stated ethnicity, CPR within 24 h before ICU admission and source of/reason for ICU admission were associated with increased risk of IHCA in ICU. For those with ROSC, increasing age, COVID-19 and increasing duration of resuscitation attempt were associated with a lower probability of survival to hospital discharge. Survivors had a reduced quality of life.
CONCLUSION: Cardiac arrest is common in ICUs and carries high mortality, although pandemic-related study disruption reduces the certainty in our results. We highlight the role of ethnicity, existence of sub-phenotypes, and trials specific to cardiac arrest in the critically ill as areas for further research to reduce incidence and improve outcomes.
TRIAL REGISTRATION: The CIRCA Study was registered at ClinicalTrials.gov on 7th January 2020 (NCT04219384).
参考来源
- Darnell R, Broomhall J, Newell C, et al. Critical Illness Related Cardiac Arrest (CIRCA): a prospective investigation of the incidence and outcome of cardiac arrest within intensive care units in the United Kingdom. Resuscitation. 2025. PMID: 41443583. doi:10.1016/j.resuscitation.2025.110933
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。